SALT LAKE CITY, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, and PATHOMIQ, Inc., a developer of artificial intelligence (AI)-enabled prognostic and...

55% of pathologist and oncologist survey respondents globally are facing stress and burnout due to increasing complexity and high workloads More than a third highlight burdens they face are detrimental to patient care, and 77% agree...

Proscia also ranks as the top vendor in diagnostic digital pathology market landscapes Philadelphia – December 5, 2024 – CB Insights named Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, to...

MANCHESTER, N.H., Sept. 30, 2024 /PRNewswire/ -- BioAI, an emerging biotech company applying multimodal artificial intelligence (AI) to novel biomarker discovery, development, and diagnostics, has announced a strategic partnership with...

Aiforia Announces a Webinar on Prognostic AI Models in Pathology Topic: Using Prognostic AI Models in Pathology: Case Colorectal Cancer Date: Thursday, June 13, 2024 Time: 11am EDT / 9am MDT / 4pm BST / 5pm CEST / 6pm EEST (60...

Roche Diagnostics is at the forefront of diagnostic certainty, empowering oncology decision-making with our VENTANA portfolio. We help our customers improve and grow by offering a wide range of high-quality medical tests and digital...